UKTI signs MoU with ABLE
Will aim at combining UK's heritage and leadership in the area of healthcare and life sciences and India's emerging and thriving…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Competition intensifies as pharma companies race to launch type II diabetes drugs
New Frost & Sullivan report analysis which products will eventually succeed and why, in the race against time
Avesthagen signs license agreement with AvestaDHATM
Through the non-exclusive agreement, Avesthagen stands to earn $30 million over the next decade
Novo Nordisk launches basal insulin for adult patients with type I and type II diabetes
To be available in India soon
US FDA accepts Boehringer Ingelheims supplemental new drug application
To be used for use of dabigatran etexilate mesylate in deep vein thrombosis and pulmonary embolism
Bilcare starts field validation studies of its nonClonableID technology
Developed in collaboration with CSIR, the system aims to secure the pharma supply chain as well as improve patient compliance
Zandu Ayurveda launches its first clinic at Nature Cure & Yoga Centre in Kolkata
Plans to launch more clinics in other select cities
Lupin receives US FDA approval for generic rifadin capsules
Is indicated for the treatment of all forms of tuberculosis